Sumitomo Pharma Co., Ltd.

SMDPY · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$261$20,453$23,116$85,393
Short-Term Investments$0$0$16,840$0
Receivables$862$83,380$74,840$94,323
Inventory$560$89,751$94,222$107,426
Other Curr. Assets$153$63,134$44,150$46,546
Total Curr. Assets$1,836$256,718$253,168$333,688
Property Plant & Equip (Net)$304$46,103$46,648$52,613
Goodwill$1,330$191,175$197,406$208,787
Intangibles$1,127$164,726$172,509$194,484
Long-Term Investments$561$7,346$72,339$0
Tax Assets$3$0$534$0
Other NC Assets$109$67,265$0$62,543
Total NC Assets$3,435$476,615$489,436$518,427
Other Assets$0$0$0$0
Total Assets$5,271$733,333$742,604$852,115
Liabilities
Payables$285$39,308$38,544$49,278
Short-Term Debt$27$50,188$46,440$254,960
Tax Payable$0$0$1,577$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,036$142,191$154,042$195,101
Total Curr. Liab.$1,348$231,687$240,603$499,339
LT Debt$1,753$259,057$258,982$119,463
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$96$0$26,550$0
Other NC Liab.$276$66,356$46,990$67,198
Total NC Liab.$2,125$325,413$332,522$186,661
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$3,472$557,100$573,125$686,000
Equity
Pref Stock$0$0$0$0
Common Stock$152$22,400$22,400$22,400
Retained Earnings$999$57,924$46,784$41,601
AOCI$652$96,591$100,977$102,796
Other Equity-$5-$682-$682-$682
Total Equity$1,798$176,233$169,479$166,115
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$5,271$733,333$742,604$852,115
Net Debt$1,519$288,792$282,306$289,030